KLRA — Kailera Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2096997 ·
Last close
$18.89
Market Cap
$2.45B
52W High
$28.23
52W Low
$18.69
ADV30
444,833
Next earnings
2026-08-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -84,660,000 | -78,865,000 | 624,756,000 | 111,826,000 | 1,056,844,000 |
| Mar 2025 | 0 | — | -20,458,000 | -17,983,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-86,511,000
Investing CF
$-31,591,000
Financing CF
$-2,980,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.82
As of
2026-05-27
Balance + Analyst (yfinance extras)
Retained Earnings
$-447,533,000
Inventory
—
Receivables
$3,208,000
ST Investments
$407,348,000
EBIT TTM
$-105,118,000
Pretax Income TTM
$-96,848,000
Interest Exp TTM
—
Analysts
5
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -158,340,000 | -148,955,000 | 692,294,000 | 1,048,752,000 | — | -120,210,000 |
| Dec 2024 | — | — | — | 178,445,000 | 397,217,000 | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.73
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | $2.46B | $34.26 | — |
| KNSA | Kiniksa Pharmaceuticals International, plc | $2.40B | $51.89 | — |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.40B | $24.35 | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $2.58B | $44.41 | — |
| IRON | Disc Medicine, Inc. | $2.60B | $67.99 | — |
News headlines (Yahoo Finance, 1h cache)
‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?
2026-06-15 04:48 · Yahoo
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock?
2026-06-12 06:50 · Yahoo
How to Play PBLS Stock After the Parabilis IPO
2026-06-11 19:12 · Yahoo
Parabilis sets a record with a $670M biotech IPO
2026-06-10 11:06 · Yahoo
Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
2026-06-05 23:32 · Yahoo
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
2026-05-28 20:05 · Yahoo
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
2026-05-26 20:02 · Yahoo
This Weight-Loss Drug Challenger Could Follow Eli Lilly's Playbook: Analyst
2026-05-13 18:43 · Yahoo
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
2026-05-13 11:30 · Yahoo
Meet The New IPO Trying To Take On Eli Lilly And Novo Nordisk In Obesity
2026-05-12 20:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.